PROKIDNEY CORP. (PROK) Form S-3 — Oct 29, 2026
ProKidney Corp. filed a $650M universal shelf registration statement on Form S-3 covering Class A common stock, preferred stock, debt securities, warrants, rights and units. The filing also includes a $200M at-the-market offering prospectus under an Open Market Sale Agreement with Jefferies LLC, with commissions up to 3.0% of gross sales price. With PROK trading at $1.52 and roughly 205.7M Class A shares outstanding, full ATM utilization would imply very substantial dilution.
Key figures
- Gross Proceeds
- 650000000
- Offering Price
- 1.52
- Shares Offered
- Up to $200,000,000 ATM; hypothetical 131,578,947 shares at $1.52
- Atm capacity
- 200000000
- Shelf capacity
- 650000000
- Sales agent commission max
- 3.0%
- Hypothetical dilution per share
- 0.56
- Shares class a outstanding jun30 2026
- 205716189
- Shares class b outstanding oct15 2026
- 93395714
- Options outstanding weighted avg price
- 3.18
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.